Attributable length of stay, mortality risk and costs of bacterial healthcare-associated infections in Australia: a retrospective case-cohort study
02 September 2020
Unbiased estimates of the health and economic impact of healthcare-associated infections (HAIs) are scarce and focus largely on patients with bloodstream infection (BSI). We sought to estimate the hospital length of stay (LOS), mortality and costs of HAIs and the differential effect on patients with an antimicrobial resistance (AMR) infection.
The health burden remains highest for BSIs, however the UTIs and respiratory tract infections (RTI) contributed most to the healthcare system expenditure.
Further reading: Clinical Infectious Diseases
Author(s): X J Lee, A J Stewardson, L J Worth, N Graves, T M Wozniak
Effective Surveillance
OUR UNDERWRITERS
Unrestricted financial support by:
 |
Antimicrobial Resistance Fighter Coalition |
 |
Evotec |
 |
JSS University |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
Technology Database
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.
